Susan M. Catalano, Ph.D.

Cognition Therapeutics Inc. 
Alzheimer's therapeutics
"Susan Catalano"
Mean distance: 13.05 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Colom-Cadena M, Toombs J, Simzer E, et al. (2024) Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease. Acta Neuropathologica. 147: 32
van Dyck CH, Mecca AP, O'Dell RS, et al. (2024) A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease. Alzheimer's Research & Therapy. 16: 20
Lizama BN, Kahle J, Catalano SM, et al. (2023) Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases. International Journal of Molecular Sciences. 24
Rishton GM, Look GC, Ni ZJ, et al. (2021) Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease. Acs Medicinal Chemistry Letters. 12: 1389-1395
LaBarbera KM, Limegrover C, Rehak C, et al. (2021) Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery. Journal of Neuroscience Methods. 358: 109180
Izzo NJ, Yuede CM, LaBarbera KM, et al. (2021) Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Limegrover CS, Yurko R, Izzo NJ, et al. (2021) Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein. Journal of Neuroscience Research
Izzo NJ, Colom-Cadena M, Riad AA, et al. (2020) Proceedings from the Fourth International Symposium on sigma-2 Receptors: Role in Health and Disease. Eneuro
Limegrover CS, LeVine H, Izzo NJ, et al. (2020) Alzheimer's Protection Effect of A673T Mutation May Be Driven by Lower Aβ Oligomer Binding Affinity. Journal of Neurochemistry
Colom-Cadena M, Spires-Jones T, Zetterberg H, et al. (2020) The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease. Alzheimer's Research & Therapy. 12: 21
See more...